2nd ESMO Consensus Conference on Lung Cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up
Johan Vansteenkiste, Lucio Crinò, Christophe Dooms et al. · Annals of Oncology · 2014
Cited by 493 works. doi:10.1093/annonc/mdu089 Open-access PDF
Authors
- Johan Vansteenkiste
- Lucio Crinò
- Christophe Dooms
- Jean-Yves Douillard
- Corinne Faivre Finn
- Eric Lim
- Gaetano Rocco
- Suresh Senan
- Paul E. Van Schil
- Giulia Veronesi
- Rolf Arno Stahel
- Solange Peters
- Enriqueta Felip
- Rolf Arno Stahel
- Enriqueta Felip
- Solange Peters
- Keith M. Kerr
- Benjamin Besse
- Johan Vansteenkiste
- Wilfried Eberhardt
References
- Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
- International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma
- Cisplatin-Based Adjuvant Chemotherapy in Patients with Completely Resected Non–Small-Cell Lung Cancer
- Guidelines for Management of Small Pulmonary Nodules Detected on CT Scans: A Statement from the Fleischner Society
- Vinorelbine plus Cisplatin vs. Observation in Resected Non–Small-Cell Lung Cancer
- Early lung cancer detection: results of the initial (prevalence) radiologic and cytologic screening in the Mayo Clinic study.
- Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB–IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial
- Management of Lung Nodules Detected by Volume CT Scanning
- Benefits and Harms of CT Screening for Lung Cancer
- Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up